GSK rais­es $1B+ from sell­ing shares in con­sumer health spin­off Ha­le­on

GSK is sell­ing off part of its stake in its con­sumer health spin­off Ha­le­on, rais­ing gross pro­ceeds of ap­prox­i­mate­ly $1 bil­lion (£804 mil­lion), the com­pa­ny said Fri­day.

The con­sumer health gi­ant that is now Ha­le­on was cre­at­ed when GSK and Pfiz­er merged their con­sumer health­care busi­ness­es in 2019, and it was spun off and list­ed on the Lon­don stock ex­change in 2022.

The British drug­mak­er agreed to sell 240 mil­lion shares of Ha­le­on for 335 pence per share. Once the sale is done, GSK will hold about 955 mil­lion or­di­nary shares in Ha­le­on, ap­prox­i­mate­ly 10.3%.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.